Brief: Chromogenics Q1 Operating Loss Widens To SEK 16.8 Million

ChromoGenics AB

19/05/2022 07:34

May 19 (Reuters) - ChromoGenics AB  CHRO.ST :
    * INTERIM REPORT JANUARY-MARCH 2022
    * IN Q1 2022, CHROMOGENICS' NET SALES AMOUNTED TO SEK 8.5
(1.6)
MILLION, AN INCREASE OF SEK 6.9 MILLION COMPARED TO
CORRESPONDING QUARTER IN 2021.
    * OPERATING LOSS FOR Q1 2022 AMOUNTED TO SEK -16.8 (-9.8)
MILLION.
    * WAR IN UKRAINE IS AFFECTING CHROMOGENICS THROUGH VOLATILE
EXCHANGE RATES, HIGHER ENERGY PRICES, HIGHER INFLATION AND A
LOWER SUPPLY OF GOODS.
    * ORDER INTAKE FOR Q1 2022 AMOUNTED TO SEK 0.8 (24.7)
MILLION.
ORDER VOLUME FOR Q2 2022 AMOUNTS TO AROUND SEK 6.8 (24.1)
MILLION

Source text for Eikon:  ID:nWkrbM9j7V 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))